Reuters logo
BRIEF-Jubilant Life Sciences says unit gets USFDA approval for Drax Exametazime
August 21, 2017 / 9:40 AM / a month ago

BRIEF-Jubilant Life Sciences says unit gets USFDA approval for Drax Exametazime

Aug 21 (Reuters) - Jubilant Life Sciences Ltd:

* Says Jubilant receives NDA approval for Drax Exametazime

* Jubilant Pharma , through Jubilant Draximage Inc gets USFDA approval for Drax Exametazime

* Approved drug is indicated for leukocyte (white blood cell) labeled scintigraphy Source text: (bit.ly/2wgESxx) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below